International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2009
Duration of hepatitis E viremia in pregnancy.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Begum Nargis, Polipalli Sunil Kumar, Husain Syed Akhtar, Kumar Ashok, Kar Premashis
Аннотация
OBJECTIVE: To investigate the duration of hepatitis E virus (HEV) infection in pregnant and non-pregnant women with acute viral hepatitis (AVH) or fulminant hepatic failure (FHF).
METHODS: A prospective study conducted with 20 pregnant women with AVH, 20 non-pregnant women with AVH, 10 pregnant women with FHF, and 9 non-pregnant women with FHF-all with HEV infection. The women were followed up on day 7, 15, 30, 60, and 90 following recruitment for the presence of HEV-RNA.
RESULTS: Of the 59 patients with HEV infection, only 2 (3.4%) revealed HEV viremia at day 30 and none of the patients was viremic at day 60 and day 90. The proportion of HEV viremia in pregnant women with AVH and FHF at day 15 was significantly higher than in non-pregnant women (88.3% vs 27.6%; P<0.001). Similarly, HEV viremia among patients with AVH was significantly higher in pregnant women compared with non-pregnant women (100% vs 55%; P<0.001).
CONCLUSION: HEV viremia may be prolonged in pregnancy.
METHODS: A prospective study conducted with 20 pregnant women with AVH, 20 non-pregnant women with AVH, 10 pregnant women with FHF, and 9 non-pregnant women with FHF-all with HEV infection. The women were followed up on day 7, 15, 30, 60, and 90 following recruitment for the presence of HEV-RNA.
RESULTS: Of the 59 patients with HEV infection, only 2 (3.4%) revealed HEV viremia at day 30 and none of the patients was viremic at day 60 and day 90. The proportion of HEV viremia in pregnant women with AVH and FHF at day 15 was significantly higher than in non-pregnant women (88.3% vs 27.6%; P<0.001). Similarly, HEV viremia among patients with AVH was significantly higher in pregnant women compared with non-pregnant women (100% vs 55%; P<0.001).
CONCLUSION: HEV viremia may be prolonged in pregnancy.